Overview of Centessa Pharmaceuticals' Upcoming Conferences
Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage pharmaceutical company dedicated to delivering innovative therapies, recently announced key participations in investor conferences. This highlights the company's commitment to transparency and investor relations.
Key Events for Investor Engagement
Centessa Pharmaceuticals is set to make its presence felt at various upcoming investor conferences. These events are crucial for the company in promoting its mission and sharing its advancements aimed at transforming patient care.
Guggenheim Healthcare Innovation Conference
One of the primary events is the Guggenheim 2nd Annual Healthcare Innovation Conference. During this event, scheduled for an early date of November 12, 2025, the management team will partake in a fireside chat session at 10:30 AM ET. This provides an excellent opportunity for investors to hear directly from the team about current developments and future prospects.
Jefferies Global Healthcare Conference
Following that, on November 18, 2025, the Jefferies Global Healthcare Conference in London will be another highlight for Centessa. The company's management will discuss their initiatives in a fireside chat at 2:00 PM GMT, or 9:00 AM ET. This conference aims to connect investors with leading companies shaping the future of healthcare.
Further Presentations and Discussions
In December 2025, Centessa Pharmaceuticals will also participate in the prestigious 37th Annual Piper Sandler Healthcare Conference on December 2 at 3:00 PM ET, followed by the 8th Annual Evercore Healthcare Conference on December 3 at 9:35 AM ET. These discussions are pivotal as they allow for deeper insights into the company's strategies and research.
Engagement in Rare Disease Summit
On December 11, 2025, the company will take part in the Oppenheimer Movers in Rare Disease Summit. This event focuses specifically on rare diseases, aligning with Centessa's mission to address unmet medical needs through innovative therapies.
Accessing the Webcasts
Investors interested in these events can access live webcasts and archived recordings on the Centessa Pharmaceuticals website under the "Events and Publications" section. This accessibility ensures that investors stay informed about the company’s progress and initiatives.
Centessa Pharmaceuticals: Company Mission and Vision
Centessa Pharmaceuticals is committed to revolutionizing patient care through its innovative approaches in drug development. The company strives to bring forward a new class of medicines, specifically focusing on the orexin receptor 2 (OX2R) agonist program. This program aims to treat a variety of symptoms associated with neurological and psychiatric conditions, such as excessive daytime sleepiness and cognitive deficits.
Conclusion
As Centessa Pharmaceuticals prepares for these significant investor conferences, their active engagement highlights their role in bringing meaningful treatments to patients in need. Their initiatives in the healthcare landscape promise to deliver compelling advances that can transform the way certain medical conditions are treated.
Frequently Asked Questions
What is Centessa Pharmaceuticals' focus?
Centessa Pharmaceuticals focuses on discovering and developing innovative therapies, particularly for neurological and psychiatric disorders.
When will Centessa present at the Guggenheim Conference?
The company will engage in a fireside chat on November 12, 2025, at the Guggenheim 2nd Annual Healthcare Innovation Conference.
How can investors access conference webcasts?
Investors can find live webcasts and archived recordings in the "Events and Publications" section on the Centessa Pharmaceuticals website.
What unique therapies is Centessa working on?
Centessa is pioneering therapies within its orexin receptor 2 (OX2R) agonist program, targeting various neurological conditions.
Is there a contact for investor inquiries?
Yes, Kristen K. Sheppard, Esq. is the SVP of Investor Relations and can be contacted for inquiries.
